FindTrial
Sign In

pap smear and liquid based Cytology screening tools in cervical cancer

Clinical utility of conventional pap smear and liquid based cytology as screening tools in cervical cancer - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109111
Enrollment
49
Registered
2026-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C538- Malignant neoplasm of overlappingsites of cervix uteri

Interventions

Intervention1: Nil: Nil

Sponsors

DR pearl reona goveas
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women 21-65 years Routine cervical cancer screening Post menopausal bleeding Post coital bleeding Spotting pv White discharge pv Irregular menstruation

Exclusion criteria

Exclusion criteria: Pregnant women Post hysterectomy Active vaginal infection Patient with history and diagnosis of genital cancer Patient on treatment for cervical cancer

Design outcomes

Primary

MeasureTime frame
To screen and compare efficacy and accuracy of conventional pap smear with liquid based cytologyTimepoint: 18months—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDR DEEPA KANGAL V

Father muller medical College

pearlreona@gmail.com8197913934

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026